Evidence map›Paper›PMID 25719427›Full record

ArticleAccounts of chemical research2015

Synthetic biology approaches to fluorinated polyketides.

B W Thuronyi, Michelle C Y Chang

Open access · greenAbstract read
In one paragraph

Article in Accounts of chemical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biocatalytic synthesis of 2-fluoro-3-hydroxypropionic acid.Frontiers in bioengineering and biotechnology · 2022
    Article
  5. Identification of Two Novel Fluorinases FromFrontiers in bioengineering and biotechnology · 2022
    Article
  6. Enzymatic synthesis of fluorinated compounds.Applied microbiology and biotechnology · 2021
    Review
  7. Article
  8. BMC chemistry · 2019
    Article
  9. Review
  10. Article
  11. Article
  12. Engineered Fluorine Metabolism and Fluoropolymer Production in Living Cells.Angewandte Chemie (International ed. in English) · 2017
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

B W Thuronyi†Department of Chemistry, University of California, Berkeley, Berkeley, California 94720-1460, United States.
Michelle C Y Chang†Department of Chemistry, University of California, Berkeley, Berkeley, California 94720-1460, United States.
University of California, Berkeley · US

Funding

Univ of Calif Berkeley Chemistry-Biology Interface ProgramT32GM066698 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHANG, CHRISTOPHER J., FRANCIS, MATTHEW B · 2004 to 2023
$7.5M
Discovery and mechanistic study of fluorine biochemistryDP2OD008696 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHANG, MICHELLE C · 2011 to 2011
$2.3M
NIGMS NIH HHS T32 GM066698NIH HHS 1 DP2 OD008696NIH HHS DP2 OD008696PHS HHS 1 T32 GMO66698
6 · The paper itself

Abstract

The catalytic diversity of living systems offers a broad range of opportunities for developing new methods to produce small molecule targets such as fuels, materials, and pharmaceuticals. In addition to providing cost-effective and renewable methods for large-scale commercial processes, the exploration of the unusual chemical phenotypes found in living organisms can also enable the expansion of chemical space for discovery of novel function by combining orthogonal attributes from both synthetic and biological chemistry. In this context, we have focused on the development of new fluorine chemistry using synthetic biology approaches. While fluorine has become an important feature in compounds of synthetic origin, the scope of biological fluorine chemistry in living systems is limited, with fewer than 20 organofluorine natural products identified to date. In order to expand the diversity of biosynthetically accessible organofluorines, we have begun to develop methods for the site-selective introduction of fluorine into complex natural products by engineering biosynthetic machinery to incorporate fluorinated building blocks. To gain insight into how both enzyme active sites and metabolic pathways can be evolved to manage and select for fluorinated compounds, we have studied one of the only characterized natural hosts for organofluorine biosynthesis, the soil microbe Streptomyces cattleya. This information provides a template for designing engineered organofluorine enzymes, pathways, and hosts and has allowed us to initiate construction of enzymatic and cellular pathways for the production of fluorinated polyketides.

Indexed as

Synthetic BiologyBiological ProductsHydrocarbons, FluorinatedMolecular StructurePolyketidesBiological ProductsHydrocarbons, FluorinatedPolyketides

Identifiers

PMID25719427
PMCPMC4833005
OpenAlexW2329355337

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.